Diffusion Pharmaceuticals Inc. Contracts & Agreements

Amended & Restated Employment Agreement, effective as of June 1, 2024, by and between CervoMed Inc. and William Elder (Filed With SEC on August 9, 2024)

Separation Agreement, effective as of May 31, 2024, by and between the CervoMed Inc. and J. William Tanner, Ph.D (Filed With SEC on August 9, 2024)

Consulting Agreement, effective as of June 1, 2024, by and between the CervoMed Inc. and J. William Tanner, Ph.D (Filed With SEC on August 9, 2024)

Form of Amended & Restated Employment Agreement, effective as of June 1, 2024, by and between the Company and William Elder (Filed With SEC on May 20, 2024)

Form of Separation Agreement, effective as of May 31, 2024, by and between the Company and J. William Tanner, Ph.D (Filed With SEC on May 20, 2024)

Form of Consulting Agreement, effective as of June 1, 2024, by and between the Company and J. William Tanner, Ph.D (Filed With SEC on May 20, 2024)

Securities Purchase Agreement, dated March 28, 2024, by and between CervoMed Inc. and each of the purchasers party thereto, related to the 2024 Private Placement (Filed With SEC on May 10, 2024)

Specimen Stock Certificate (Filed With SEC on March 29, 2024)

Description of Securities of CervoMed Inc (Filed With SEC on March 29, 2024)

Form of Stock Option Award Agreement under 2018 Employee, Director and Consultant Equity Incentive Plan (Filed With SEC on March 29, 2024)

Form of Indemnification Agreement between CervoMed Inc. and each of its directors and officers (Filed With SEC on March 29, 2024)

Form of Pre-Funded Warrant (Filed With SEC on March 28, 2024)

Form of Series A Warrant (Filed With SEC on March 28, 2024)

Securities Purchase Agreement, dated March 28, 2024, by and between CervoMed Inc. and each of the purchasers party thereto (Filed With SEC on March 28, 2024)

Amendment to Pre-Funded Warrant, dated as February 26, 2024, by and between CervoMed Inc. and The Joshua S. Boger 2021 Trust DTD 12/09/2021 (Filed With SEC on February 28, 2024)

Amended & Restated Employment Agreement, dated February 1, 2024, by and between CervoMed Inc. and John Alam, M.D (Filed With SEC on February 2, 2024)

Amended & Restated Employment Agreement, dated February 1, 2024, by and between CervoMed Inc. and Robert J. Cobuzzi, Jr., Ph.D (Filed With SEC on February 2, 2024)

Employment Agreement, dated February 1, 2024, by and between CervoMed Inc. and Kelly Blackburn, M.H.A (Filed With SEC on February 2, 2024)

Employment Agreement, dated November 15, 2023, by and between CervoMed Inc. and J. William Tanner (Filed With SEC on November 17, 2023)

Subscription Agreement, dated July 10, 2023 (Filed With SEC on November 13, 2023)

Form of Warrant (Filed With SEC on August 17, 2023)

Form of AI EIPP Holdings LLC Warrant (Filed With SEC on August 17, 2023)

Form of Pre-Funded Warrant (Filed With SEC on August 17, 2023)

Form of Indemnification Agreement between the Company and each of its directions and officers (Filed With SEC on August 17, 2023)

Separation Agreement and General Release, dated May 15, 2023, by and between Diffusion Pharmaceuticals Inc. and William K. Hornung (Filed With SEC on May 19, 2023)

Option and License Agreement, dated as of August 27, 2012, by and between EIP Pharma LLC and Vertex Pharmaceuticals Incorporated (Filed With SEC on May 11, 2023)

Amendment No.1, dated as of April 8, 2014, to Option and License Agreement, dated August 27, 2012, by and between EIP Pharma LLC and Vertex Pharmaceuticals Incorporated (Filed With SEC on May 11, 2023)

Amendment No.2, dated as of November 17, 2015, to Option and License Agreement, dated August 27, 2012, as amended April 18, 2014, by and between EIP Pharma LLC and Vertex... (Filed With SEC on May 11, 2023)

Executive Employment Agreement, dated as of April 2, 2018, by and between EIP Pharma, Inc., and Sylvie Gregoire (Filed With SEC on May 11, 2023)

Amendment No. 1, dated as of March 4, 2019, to Executive Employment Agreement, dated as of April 2, 2018, by and between EIP Pharma, Inc., and Sylvie Gregoire (Filed With SEC on May 11, 2023)

Executive Employment Agreement, effective as of April 2, 2018, by and between EIP Pharma, Inc., and John Alam, M.D (Filed With SEC on May 11, 2023)

Offer Letter, dated as of April 29, 2018, by and between EIP Pharma, Inc., and Kelly Blackburn (Filed With SEC on May 11, 2023)

Amendment, dated as of January 29, 2019, to Offer Letter, dated April 29, 2018, by and between EIP Pharma, Inc., and Kelly Blackburn (Filed With SEC on May 11, 2023)

2018 Employee, Director and Consultant Equity Incentive Plan, effective as of March 28, 2019 (Filed With SEC on May 11, 2023)

Agreement and Plan of Merger, dated as of March 30, 2023, by and among Diffusion Pharmaceuticals Inc., EIP Pharma, Inc. and Dawn Merger Sub Inc (Filed With SEC on March 30, 2023)

Form of EIP Pharma, Inc. Stockholder Support Agreement, dated as of March 30, 2023 (Filed With SEC on March 30, 2023)

Form of Lock-up Agreement, dated as of March 30, 2023 (Filed With SEC on March 30, 2023)

Amendment, dated March 29, 2023, to Employment Agreement, dated September 8, 2020, by and between Diffusion Pharmaceuticals Inc. and Robert J. Cobuzzi, Ph.D (Filed With SEC on March 30, 2023)

Amendment, dated March 29, 2023, to Employment Agreement, dated September 21, 2018, by and between Diffusion Pharmaceuticals Inc. and William Hornung (Filed With SEC on March 30, 2023)

Amendment, dated March 29, 2023, to Employment Agreement, dated September 23, 2020, by and between Diffusion Pharmaceuticals Inc. and William Elder (Filed With SEC on March 30, 2023)

Separation Agreement and General Release, effective as of March 8, 2023, by and between Diffusion Pharmaceuticals and Christopher D. Galloway, M.D (Filed With SEC on March 24, 2023)

Separation Agreement and General Release, effective as of March 8, 2023, by and between Diffusion Pharmaceuticals and Raven Jaeger (Filed With SEC on March 24, 2023)

Form of Separation Agreement and General Release by and between Diffusion Pharmaceuticals Inc. and certain executive employees (Filed With SEC on February 16, 2023)

Agreement, dated as of December 15, 2022, by and among Diffusion Pharmaceuticals Inc, LifeSci Special Opportunities Master Fund Ltd., LifeSci Special Opportunities Partners L.P.,... (Filed With SEC on December 16, 2022)

At-The-Market Sales Agreement, dated July 22, 2022, by and between Diffusion Pharmaceuticals Inc. and BTIG, LLC (Filed With SEC on July 22, 2022)

Employment Agreement, effective May 18, 2022, by and between the Company and Raven Jaeger, M.S (Filed With SEC on June 28, 2022)

Form of Stock Option Award Agreement under 2015 Equity Incentive Plan (Filed With SEC on March 18, 2022)

Form of Director RSU Agreement under 2015 Equity Incentive Plan (Filed With SEC on March 18, 2022)

Form of Subscription Agreement between Diffusion Pharmaceuticals Inc. and the investors named therein, dated March 18, 2022 (Filed With SEC on March 18, 2022)

Amended & Restated Underwriting Agreement, dated February 11, 2021, by and between Diffusion Pharmaceuticals Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on February 18, 2021)

Form of Underwriter Warrant (Filed With SEC on February 18, 2021)

Employment Agreement, dated as of October 19, 2020, by and between Diffusion Pharmaceuticals Inc. and Christopher D. Galloway (Filed With SEC on October 20, 2020)

Employment Agreement, dated as of September 23, 2020, by and between Diffusion Pharmaceuticals Inc. and William R. Elder (Filed With SEC on September 25, 2020)

Separation Agreement, dated as of September 8, 2020, by and between Diffusion Pharmaceuticals Inc. and David G. Kalergis (Filed With SEC on September 9, 2020)

Employment Agreement, dated as of September 8, 2020, by and between Diffusion Pharmaceuticals Inc. and Robert J. Cobuzzi, Ph.D (Filed With SEC on September 9, 2020)

Form of Warrant (Filed With SEC on May 20, 2020)

Form of Securities Purchase Agreement, dated May 18, 2020, by and among the Company and the purchasers party thereto (Filed With SEC on May 20, 2020)

Engagement Letter, dated March 27, 2020, by and between the Company and H.C. Wainwright & Co. LLC (Filed With SEC on May 20, 2020)

Form of New Warrant issued on May 8, 2020 (Filed With SEC on May 8, 2020)

Form of Placement Agent Warrant issued on May 8, 2020 (Filed With SEC on May 8, 2020)

Warrant Exercise Agreement, dated May 6, 2020, by and between Diffusion Pharmaceuticals Inc. and the purchaser thereto (Filed With SEC on May 8, 2020)

Separation Agreement, dated March 12, 2020, by and between Diffusion Pharmaceuticals Inc. and John L. Gainer (Filed With SEC on March 18, 2020)

Consulting Agreement, dated March 12, 2020, by and between Diffusion Pharmaceuticals Inc. and John L. Gainer (Filed With SEC on March 18, 2020)

Description of Securities (Filed With SEC on March 17, 2020)

Form of Warrant (Filed With SEC on December 13, 2019)

Form of Placement Agent Warrant (Filed With SEC on December 13, 2019)

Form of Securities Purchase Agreement, dated December 11, 2019, by and among the Company and the purchasers party thereto (Filed With SEC on December 13, 2019)

Engagement Letter, dated December 11, 2019, between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on December 13, 2019)

Form of Series I Warrant (Filed With SEC on November 13, 2019)

Form of Series II Warrant (Filed With SEC on November 13, 2019)

Form of Pre-Funded Warrant (Filed With SEC on November 13, 2019)

Form of Wainwright Warrant (Filed With SEC on November 13, 2019)

Securities Purchase Agreement (Filed With SEC on November 13, 2019)

Form of Common Warrant (Filed With SEC on November 8, 2019)

Form of Pre-Funded Warrant (Filed With SEC on November 8, 2019)

Form of Underwriters Warrant (Filed With SEC on November 8, 2019)

Form of Placement Agents Warrant (Filed With SEC on November 8, 2019)

Engagement Letter, dated October 7, 2019, by and between Diffusion Pharmaceuticals Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on November 8, 2019)

Form of Securities Purchase Agreement (Filed With SEC on November 8, 2019)

Form of Underwriting Agreement, dated [_______], by and between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on October 28, 2019)

Form of Common Warrant (Filed With SEC on October 28, 2019)

Form of Pre-Funded Warrant (Filed With SEC on October 28, 2019)

Form of Underwriters Warrant (Filed With SEC on October 28, 2019)

Form of Warrant (Filed With SEC on May 28, 2019)

Form of Placement Agent Warrant (Filed With SEC on May 28, 2019)

Form of Securities Purchase Agreement, dated May 23, 2019, by and among the Company and the purchasers party thereto (Filed With SEC on May 28, 2019)

Engagement Letter, dated May 3, 2019, between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on May 28, 2019)

Amended and Restated Employment Agreement, dated as of September 21, 2018, by and between William Hornung and Diffusion Pharmaceuticals Inc (Filed With SEC on September 27, 2018)

Separation Letter, effective as of September 26, 2018, by and between Ben L. Shealy and Diffusion Pharmaceuticals Inc (Filed With SEC on September 27, 2018)

Form of Diffusion Pharmaceuticals Inc. Stock Option Award Agreement (Filed With SEC on April 2, 2018)

Form of Underwriters Warrant (Filed With SEC on January 22, 2018)

Underwriting Agreement, dated January 18, 2018, by and between Diffusion Pharmaceuticals Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on January 19, 2018)

Form of Warrant (Filed With SEC on January 19, 2018)

Form of Underwriting Agreement, by and between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on January 16, 2018)

Form of Warrant to be issued to the underwriter in this offering (Filed With SEC on January 16, 2018)

Form of Warrant to be issued to investors in this offering (Filed With SEC on January 16, 2018)

DIFFUSION PHARMACEUTICALS INC. REGISTRATION RIGHTS AGREEMENT DATED [], 2017 (Filed With SEC on May 15, 2017)

DEED OF LEASE (Filed With SEC on May 15, 2017)

STOCK OPTION AGREEMENT (Filed With SEC on March 31, 2017)

AMENDMENT TO PLACEMENT AGENCY AGREEMENT (Filed With SEC on March 31, 2017)

COMMON STOCK PURCHASE WARRANT DIFFUSION PHARMACEUTICALS INC. (Filed With SEC on March 15, 2017)

PLACEMENT AGENCY AGREEMENT (Filed With SEC on March 15, 2017)

FORM OF SUBSCRIPTION AGREEMENT (Filed With SEC on March 15, 2017)

EMPLOYMENT AGREEMENT (Filed With SEC on October 13, 2016)

DIFFUSION PHARMACEUTICALS INC. CONVERTIBLE 6.0% PROMISSORY NOTE (Filed With SEC on October 3, 2016)

SETTLEMENT AND RELEASE AGREEMENT (Filed With SEC on October 3, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on September 8, 2016)

DIFFUSION PHARMACEUTICALS LLC CONVERTIBLE [____]% PROMISSORY NOTE (Filed With SEC on March 25, 2016)

INDEMNIFICATION AGREEMENT (Filed With SEC on March 25, 2016)

Option Agreement (Filed With SEC on March 25, 2016)

FORM OF PARENT Stockholder VOTING AND LOCK-UP Agreement (Filed With SEC on January 8, 2016)

CONTINGENT VALUE RIGHTS AGREEMENT (Filed With SEC on January 8, 2016)

AGREEMENT AND PLAN OF MERGER BY AND AMONG RESTORGENEX CORPORATION, ARCO MERGER SUB, LLC AND DIFFUSION PHARMACEUTICALS LLC DATED AS OF DECEMBER 15, 2015 Table of Contents (Filed With SEC on December 15, 2015)

PLAN OF CONVERSION OF RESTORGENEX CORPORATION A NEVADA CORPORATION INTO RESTORGENEX CORPORATION, A DELAWARE CORPORATION (Filed With SEC on June 18, 2015)

INDEMNIFICATION AGREEMENT (Filed With SEC on June 18, 2015)

RESTORGENEX CORPORATION 2015 EQUITY INCENTIVE PLAN (Filed With SEC on June 18, 2015)

INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on June 18, 2015)

STOCK OPTION AGREEMENT (Filed With SEC on June 18, 2015)

RESIGNATION AGREEMENT (Filed With SEC on May 1, 2015)

COMMON STOCK PURCHASE WARRANT RESTORGENEX CORPORATION Warrant Shares: 351,060 Initial Exercise Date: June 6, 2014 (Filed With SEC on April 3, 2015)

COMMON STOCK PURCHASE WARRANT RESTORGENEX CORPORATION (Filed With SEC on April 3, 2015)

DEBT CONVERSION AGREEMENT (Filed With SEC on April 3, 2015)

STOCK OPTION AGREEMENT (Filed With SEC on April 3, 2015)

CONSULTING AGREEMENT (Filed With SEC on November 12, 2014)

Addendum to Executive Employment Agreement of David Sherris (Filed With SEC on November 12, 2014)

INDEMNIFICATION AGREEMENT (Filed With SEC on October 3, 2014)

OFFICE LEASE AGREEMENT (Filed With SEC on September 10, 2014)

SETTLEMENT AGREEMENT & RELEASE (Filed With SEC on August 14, 2014)

INDEPENDENT CONTRACTOR AGREEMENT (Filed With SEC on August 14, 2014)

Addendum to Executive Employment Agreement of Yael Schwartz (Filed With SEC on August 14, 2014)

COMMON STOCK PURCHASE WARRANT RESTORGENEX CORPORATION Warrant Shares: 355,699 Initial Exercise Date: June 6, 2014 (Filed With SEC on August 14, 2014)

STOCK OPTION AGREEMENT (Filed With SEC on August 14, 2014)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on June 9, 2014)

AMENDMENT TO SETTLEMENT AGREEMENT ANDSTIPULATION (Filed With SEC on June 9, 2014)

SEVERANCE AGREEMENT AND GENERAL RELEASE (Filed With SEC on June 9, 2014)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on May 30, 2014)

COMMON STOCK PURCHASE WARRANT RESTORGENEXCORPORATION (Filed With SEC on April 29, 2014)

SUBSCRIPTION AGREEMENT (Filed With SEC on April 29, 2014)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on April 29, 2014)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on April 2, 2014)

RestorGenex Corporation SECURED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on March 21, 2014)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 10, 2014)

AGREEMENT AND PLAN OF MERGER (Filed With SEC on March 7, 2014)

Stratus Media Group, Inc. SECURED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on February 7, 2014)

Stratus Media Group, Inc. 10% SECURED CONVERTIBLE PROMISSORYNOTE (Filed With SEC on December 27, 2013)

NOTE PURCHASE AGREEMENT (Filed With SEC on December 27, 2013)

SECURITY AGREEMENT (Filed With SEC on December 27, 2013)

SISKEY CAPITAL, LLC 4521 Sharon Road, Suite 450 Charlotte, NC 28211 (Filed With SEC on December 27, 2013)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on November 22, 2013)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 22, 2013)

EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on November 22, 2013)

SUBLICENSE AGREEMENT (Filed With SEC on November 22, 2013)

COLLABORATION AGREEMENT (Filed With SEC on November 22, 2013)

CANTERBURY LABORATORIES, LLC MASTER SERVICES AGREEMENT (Filed With SEC on November 22, 2013)

MASTER CONTRACT SERVICES AGREEMENT (Filed With SEC on November 22, 2013)

Service Agreement (Filed With SEC on November 22, 2013)

AGREEMENT AND PLAN OF MERGER (Filed With SEC on October 2, 2013)

DEBT CONVERSION AGREEMENT (Filed With SEC on June 18, 2013)

SERIES E PREFERRED STOCK CONVERSION AND WARRANT EXERCISE AGREEMENT (Filed With SEC on June 18, 2013)

EMPLOYMENT AGREEMENT (Filed With SEC on April 16, 2013)

STRATUS MEDIA GROUP, INC. _______________ AMENDED AND RESTATED CERTIFICATE OF DESIGNATIONS OF SERIES E CONVERTIBLE PREFERRED STOCK (Pursuant to Section78.195 of the General... (Filed With SEC on November 16, 2012)

STRATUS MEDIA GROUP, INC. WARRANT TO PURCHASE COMMON STOCK To Purchase 3,333,333 Shares of CommonStock (Filed With SEC on November 16, 2012)

STRATUS MEDIA GROUP, INC. WARRANT TO PURCHASE COMMON STOCK To Purchase 1,666,666 Shares of CommonStock (Filed With SEC on November 16, 2012)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 16, 2012)

SECURITY AGREEMENT (Filed With SEC on November 16, 2012)

EMPLOYMENT AGREEMENT (Filed With SEC on August 17, 2012)

CONSULTING AGREEMENT (Filed With SEC on June 29, 2012)

SEPARATION AND RELEASE AGREEMENT (Filed With SEC on June 29, 2012)

PROMISSORY NOTE $1,000,000January 25, 2012Santa Barbara, California (Filed With SEC on January 31, 2012)

STRATUS MEDIA GROUP, INC. OPTION TO PURCHASE COMMON STOCK To Purchase Shares of Common Stock of ProElite, Inc. (Filed With SEC on January 31, 2012)

W I T N E S S E T H: (Filed With SEC on September 22, 2011)

STRATUS MEDIA GROUP, INC. 3 East De La Guerra Street, 2nd Floor Santa Barbara, California 93101 June 13, 2011 (Filed With SEC on June 20, 2011)

STRATUS MEDIA GROUP, INC. CERTIFICATE OF DESIGNATIONS OF THE SERIES C10% CONVERTIBLE PREFERRED SHARES Pursuant to Section 78.195 of the General Corporation Law of the State of... (Filed With SEC on May 27, 2011)

STRATUS MEDIA GROUP, INC. CERTIFICATE OF DESIGNATIONS OF THE SERIES D10% CONVERTIBLE PREFERRED SHARES Pursuant to Section 78.195 of the General Corporation Law of the State of... (Filed With SEC on May 27, 2011)

STRATUS MEDIA GROUP, INC. _______________ CERTIFICATE OF DESIGNATIONS OF SERIES E CONVERTIBLE PREFERRED STOCK (Pursuant to Section 78.195 of the General Corporation Law of the... (Filed With SEC on May 27, 2011)

WARRANT TO PURCHASE COMMON STOCK OF STRATUS MEDIA GROUP, INC. (Filed With SEC on May 27, 2011)

STRATUS MEDIA GROUP, INC. WARRANT TO PURCHASE COMMON STOCK To Purchase [______] Shares of Common Stock (Filed With SEC on May 27, 2011)

WARRANT TO PURCHASE COMMON STOCK OF STRATUS MEDIA GROUP, INC. (Filed With SEC on May 27, 2011)

STRATUS MEDIA GROUP, INC. CERTIFICATE OF DESIGNATIONS OF THE SERIES C 10% CONVERTIBLE PREFERRED SHARES Pursuant to Section 78.195 of the General Corporation Law of the State of... (Filed With SEC on April 26, 2011)

AMENDMENT NO. 7 TO STRATEGIC INVESTMENT AGREEMENT (Filed With SEC on April 26, 2011)

EMPLOYMENT AGREEMENT (Filed With SEC on April 26, 2011)

AMENDMENT TO STRATEGIC INVESTMENT AGREEMENT (Filed With SEC on February 26, 2010)

PROELITE, INC. and STRATUS MEDIA GROUP, INC. STRATEGIC INVESTMENT AGREEMENT October 9, 2009 (Filed With SEC on October 22, 2009)

DATED 2008-07-27 Emanuele ROSSI Vincenzo PETRETTI Giuseppe SCIRETTA Philippe FAVRE Nicolas PELLOLIO Paul SANCHEZ Pierangelo BOTTINELLI Michel SCALEA Arnaud LIGUER-LAUBHOUET... (Filed With SEC on July 30, 2008)

Exhibit 10.2 AMENDMENT TO AGREEMENT AND PLAN OF MERGER (Filed With SEC on March 14, 2008)

Exhibit 10.3 EMPLOYMENT AGREEMENT (Filed With SEC on March 14, 2008)

Category

Industry

Companies

Contracts

Diffusion Pharmaceuticals Inc. Contracts & Agreements